MCM
MLAB icon

Monimus Capital Management’s Mesa Laboratories MLAB Stock Holding History

Monimus Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Sell
55,344
-45,948
-45% -$4.63M 1.28% 30
2026
Q1 		$8.96M Buy
101,292
+60,450
+148% +$5.21M 2.48% 14
2025
Q4 		$3.21M Buy
40,842
+7,098
+21% +$540K 2.12% 21
2025
Q3 		$2.26M Buy
+33,744
New +$2.43M 1.39% 29

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Monimus Capital Management's MLAB Position: Q2 2026 in Review

Monimus Capital Management reduced its Mesa Laboratories (MLAB) stake by 45% in Q2 2026, selling an estimated $4.63M and leaving 55,344 shares worth $5.51M. The position accounts for 1.28% of the portfolio, ranked #30.

Monimus Capital Management first reported a position in MLAB in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.96M in Q1 2026. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Monimus Capital Management held 55,344 shares of Mesa Laboratories worth $5.51M as of Q2 2026.
  • Monimus Capital Management sold 45,948 Mesa Laboratories shares in Q2 2026, an estimated $4.63M.
  • Mesa Laboratories made up 1.28% of Monimus Capital Management's portfolio in Q2 2026, its #30 holding.
  • Monimus Capital Management first reported a position in Mesa Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Monimus Capital Management's Mesa Laboratories position peaked at $8.96M in Q1 2026.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Monimus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.